5th TPD and Induced Proximity Summit Europe

Conference Highlights

5th TPD & Induced Proximity Summit Europe - Home
The 5th TPD & Induced Proximity Summit returns as Europe’s definitive meeting for uniting Targeted Protein Degradation professionals within Europe.

25th - 27th March
London, UK
Accelerating PROTAC’s, Glues & Novel Non-Degrading TACs to Patients Faster
Induced proximity medicines are revolutionising therapeutic strategies, offering groundbreaking solutions for disease treatment.
In 2024 alone, PhoreMost secured $50 million in Series B financing for its degrader programs, while Merck KGaA partnered with C4 Therapeutics in a $756 million deal focused on protein degraders.